ArticleCureus2024
Paroxysmal Atrial Fibrillation as the First Presentation of Coronary Artery Spasm.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- When SVT is Not Benign: Troponin Elevation Revealing Coronary Vasospasm, A Case Report.Clinical medicine insights. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atrial fibrillation (AF) is a common arrhythmia with increasing incidence and prevalence, associated with increased morbidity and mortality. The list of predisposing factors is extensive and includes coronary artery disease (CAD) as a significant trigger. Coronary spasm, an uncommon form of CAD, can very rarely present with AF. We report an adult male with no significant risk factors or family history, except for smoking, who presented with recurrent palpitations diagnosed and managed as paroxysmal AF. Within one year, the patient experienced recurrent attacks of acute chest pain associated with paroxysms of AF. Coronary angiography showed normal coronary anatomy, and coronary spasm was confirmed by a provocation test, which was associated with the development of arrhythmia. The calcium channel blocker (CCB) nifedipine and isosorbide mononitrate prevented the recurrence of these attacks. CAD should be managed as part of the holistic management of paroxysmal AF, and coronary artery spasms should be considered and treated with coronary dilators, especially CCBs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.